亚洲最大赌博网站

Guantao advises CRHMS on issuing A-shares to specific investors, successfully registered with CSRC

On August 29, 2023, China Reform Health Management and Services Group Co., Ltd. (stock code: 000503; stock Abbr: CRHMS) obtained the approval of registration from the China Securities Regulatory Commission (CSRC) for issuing A-shares to specific investors. 

CRHMS is deeply rooted in the healthcare information industry, closely orienting towards the national strategy of "Healthy China" and the general requirements of the State for the "Three Coordinated Medical Reforms", and in accordance with the development goals and business directions determined by the Company's strategic plan of "One Body and Two Wings, Two-wheel Drive, Digital Empowerment, and Healthy Ecology", it has built the basic platform by taking digital medical insurance as the body and digital medical treatment and digital medicine as the two wings, constantly promoted mechanism innovation, deeply explored data value, actively carried out investment and cooperation, and strived to become a pioneer of digital medical insurance, a builder of digital medicine and digital medical treatment, and an innovator of Internet health security services, and a first-class healthcare service company. The capital raised by CRHMS in this IPO will be no more than 794 million RMB yuan, and will be further invested in the direction of the digitalization of "three medical treatments", the integration of healthcare services, and shall seize the opportunities for the development of the healthcare information industry. 

Guantao served as the issuer's PRC legal counsel for this CRHMS IPO . The team was led by Guantao partner ZHANG Wenliang, and assisted by senior associates ZHAN Menglu and BIAN Zhenhua.